✓ Last verified: January 26, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS Eastlake serves South Bay San Diego from its Chula Vista location on Lane Avenue, offering insurance-covered Spravato (esketamine nasal spray) and NeuroStar TMS therapy. This center is essential for Chula Vista, Eastlake, Bonita, National City, and south San Diego County patients who would otherwise face a significant drive north for advanced depression treatment. Greenbrook’s standardized national protocols ensure the same quality of care available at their other locations throughout California.
| Google Reviews | ⭐ 4.5 (National Network) |
| Location | Chula Vista, California |
| Address | 900 Lane Avenue, Suite 114, Chula Vista, CA 91914 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato (Esketamine Nasal Spray), NeuroStar TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, MDD with Suicidal Ideation |
| Cost | Covered by most major insurance plans |
| Insurance | Most major insurance accepted for both Spravato and TMS |
| KAP Available | No — Spravato administered under medical supervision (not KAP) |
| Clinical Lead | Greenbrook TMS Clinical Team |
HealingMaps Take: South Bay San Diego has historically had fewer mental health specialty options compared to central and north San Diego. The Eastlake Greenbrook location addresses this gap with insurance-covered Spravato and TMS, giving Chula Vista and South Bay residents local access to advanced depression treatments. For the area’s large and diverse population, insurance coverage removes the financial barrier that makes self-pay ketamine clinics inaccessible to many. This is particularly meaningful for South Bay residents who may not have the flexibility to regularly commute to central San Diego for treatment.
Market Position: Greenbrook TMS (Eastlake) is a Spravato-certified clinic in the Vista metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS (Eastlake)’s posted price: Covered by most major insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions Greenbrook TMS (Eastlake) treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS (Eastlake) offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS (Eastlake) treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
TMS therapy is also available at this clinic, alongside ketamine and Spravato. Unlike cash-pay ketamine, TMS is covered by most major insurance plans for treatment-resistant depression. TMS is FDA-cleared for treatment-resistant depression (since 2008), OCD via Deep TMS, anxious depression, and adolescent MDD ages 15–21. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in California and across the United States.
See also: — related HealingMaps coverage.
Save 40%+ on Your Medical Supplies
GPO-level pricing negotiated through Pipeline Medical, exclusively for Healing Health Alliance members. Find out how much we can save your clinic — no obligation, no contracts.
Leave a Reply